Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

XBiotech Q2 EPS $(0.06) Up From $(0.43) YoY

Author: Benzinga Newsdesk | August 13, 2025 06:01pm
XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.06) per share. This is a 86.05 percent increase over losses of $(0.43) per share from the same period last year.

Posted In: XBIT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist